Click on headlines below to download research

Interim data from Phase IIa ETHERAL AD study
Oryzon Genomics | 18/07/2019

On 15 July 2019, Oryzon presented interim data from the Phase IIa ETHERAL trial at the Alzheimer's Association International Conference (AAIC 2019)…

Restructured with new leadership
Codere | 18/07/2019

Codere is an established retail gaming operator in Latin America, Spain and Italy. Following macro and financial difficulties, it completed a successful…

Positive signals from first ALICE trial dataset
Oryzon Genomics | 18/06/2019

On 14 June 2019, Oryzon presented dose-finding data from the Phase II ALICE trial at the 24th Congress of the European Hematology Association (EHA-2019)…

Q1 off to a good start, raising margin expectations
ADL Bionatur Solutions | 23/05/2019

ADL Bionatur Solutions (ADL-BS) recently reported Q119 results, showing positive €0.11m EBITDA, and over 134% year-on-year revenue growth to €10m,…

Becat roll-out benefits top-line growth
Laboratorios Farmaceuticos ROVI | 10/05/2019

Laboratorios Farmacéuticos ROVI (ROVI) reported Q119 operating revenue of €82.2m (+8% y-o-y), driven by strong growth in the speciality pharmaceutical…

Solid Q119 growth
ADL Bionatur Solutions | 09/05/2019

ADL Bionatur Solutions (ADL-BS) reported robust Q119 growth, with revenue of €9.97m (up 134% year-on-year), driven largely by increased capacity utilisation…

First vafidemstat efficacy data
Oryzon Genomics | 29/04/2019

In April 2019, Oryzon released the results from the first two cohorts in the Phase II REIMAGINE trial, namely borderline personality disorder (BPD) and…

DORIA Phase III trial hits primary endpoint
Laboratorios Farmaceuticos ROVI | 19/03/2019

Laboratorios Farmacéuticos ROVI (ROVI) has announced top-line data from the pivotal Phase III PRISMA-3 trial evaluating DORIA (ISM risperidone)…

Executive interview – ROVI
Executive interview – ROVI | 06/03/2019

Laboratorios Farmacéuticos ROVI is a fully integrated, profitable Spanish pharmaceutical company established in 1946 which listed on the Madrid Stock…